Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. Valeant Pharma International
VRX

Buy VRX Stock

VRX
See VRX stock price and Buy/Sell Valeant Pharma International with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.
VRX

Valeant Pharma International (VRX)

—

We couldn’t load this chart.

Some stock charts might currently not be supported. To try again, please refresh this page.

About Valeant Pharma International (VRX)

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical ...Read more
Market Cap
$3.9B
1 Year High
$32.54
Volume
860.74k
1 Year Low
$7.80
Price to Earnings Ratio
—
Open
$11.07
Dividend Rate
—
High
$11.34
Dividend Yield
—
Low
$10.78

Community

People who own or watch VRX stock

VRX stock rating

What analysts recommend for VRX stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
1.9

VRX price target

What analysts think VRX will be worth
Low $7.80
High $32.54
Current $11.11
Target $28

VRX earnings

The value each share was expected to gain vs. the value that each share actually gained
1.27
0.78
0.3
-0.19
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Expected EPS
Q2 2022
$1
Actual EPS
Q2 2022
–

Buy VRX Stock

VRX
See VRX stock price and Buy/Sell Valeant Pharma International with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.

Community

People who own or watch VRX stock
  • colleenc avatar
  • Buster1973 avatar
  • pajenterprizez avatar
  • DareyA avatar
  • alexasgari avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency trading is provided by Apex Crypto LLC (“Apex Crypto”). Apex Crypto is not a registered broker-dealer or FINRA member and is not affiliated with Public Holdings or any of its subsidiaries. Cryptocurrencies are not securities and your cryptocurrency holdings are not FDIC or SIPC insured. Crypto trading involves a substantial risk of loss as there is significant volatility in the price of cryptocurrencies.

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.

View Full Disclosures